February 27, 2024 Media Coverage from ARCH Venture Partners | Share Managing Director Kristina Burow named to STAT’s 2024 STATUS list alongside other top leaders shaping the industry
November 1, 2023 Media Coverage from ARCH Venture Partners | Share With ARCH funding, Gate Biosciences finds new way to attack diseases
September 21, 2023 Media Coverage from ARCH Venture Partners | Share Four ARCH-backed companies named to Endpoints 11 list of most exciting biotech startups in 2023
July 14, 2023 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Appointment of Kent Rogers as Venture Partner
May 25, 2023 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Appointment of Kevin Hrusovsky as Venture Partner
May 23, 2023 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Appointment of Jami Rubin as Venture Partner
April 25, 2023 Media Coverage from ARCH Venture Partners | Share ARCH leads Series A for Orbital, supporting research to unleash full potential of RNA medicines
April 6, 2023 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Appointment of Brian Cuneo as Senior Partner
March 7, 2023 Media Coverage from ARCH Venture Partners | Share ARCH leads Volastra $60 million financing round
January 27, 2023 Media Coverage from ARCH Venture Partners | Share The New York Times profiled ARCH-backed Paradigm, which aims to simplify clinical trials
December 15, 2022 Media Coverage from ARCH Venture Partners | Share Gates, Bezos back $75M round led by ARCH for Synchron’s drill-free brain-computer interface implant
December 8, 2022 Press Releases from ARCH Venture Partners | Share ARCH Venture Partners Announces Patrick Weiss as Venture Partner
